anonymous
Guest
anonymous
Guest
Well, I wonder if Allergan will be buying Pfizer to avoid all the political consequences of an inversion deal near an election year. Not only that, Ian Read and his cronies would probably see the value of their options and stock go up 35% as some analysts have suggested. This would be far more than if Pfizer were to buy Allergan. Ian Read, at the age of 62 would be able to fly off into the sunset with a nice bump in his retirement income. Stay tuned, we should know by Thanksgiving.